Was Johnson & Johnson Hiding Something During the Trial Which Cost the Company $72 Million?

In a recent talcum powder verdict, which cost pharmaceutical giant Johnson & Johnson $72 million, the jury foreman said later it was clear J & J was “hiding something.” The case was that of Jacqueline Fox, of Birmingham, Alabama, who died from ovarian cancer recently, at the age of 62. Her family brought a wrongful death suit against Johnson & Johnson, which was heard before a St. Louis, Missouri jury. For many years, Fox had used both J & J Shower to Shower and J & J Baby Powder for feminine hygiene.

More Than 1,200 Cases Filed Against Johnson & Johnson

The Fox trial was the first state court case to go to trial, however Johnson & Johnson faces at least 1,200 more lawsuits over talc products and the link to ovarian cancer. The jury awarded the Fox family $10 million in compensatory damages and $62 million in punitive damages, after only four hours of deliberation. Johnson & Johnson spokeswoman, Carol Goodrich, sent an e-mailed statement claiming that while the company sympathizes with the family of Jacqueline Fox, they continue to believe the safety of cosmetic talk is “supported by decades of scientific evidence.”

Research Links Talc to an Increased Risk of Ovarian Cancer

Despite J & J’s claims to the contrary, there is a significant body of research which links talc used for genital hygiene to a significant increased risk of ovarian cancer. One study places the numbers at a 90 percent increased risk.

Prior Federal J & J Verdict Puzzles Many

A prior verdict found that J & J was negligent and their negligence increased the risk of harm to the plaintiff. However, for an unknown reason that jury did not award damages. One member of the jury stated that while the jury believed J & J should have warned women of the risks associated with talcum powder used for feminine hygiene, they were not 100 percent convinced that plaintiff’s cancer resulted from the use of talc.

A Statistical Link Between Talc Used for Feminine Hygiene and Ovarian Cancer?

Talc, the softest of all minerals, is used in cosmetics, as a food additive, in paper and paints, in roofing materials, in ceramic and rubber products and as a filler in capsules and pills. Issues came to light in 1971, when British researchers analyzed 13 ovarian tumors under a microscope. These researchers found deeply embedded talc particles embedded in ten of those tumors. A study published in the journal, Cancer, concluded there was a statistical link between using talc powder in the genital region and ovarian cancer. As recently as 2015, an Epidemiology article found that women who used talc in the genital region had a 33 percent higher rate of ovarian cancer than women who did not use talc. It appears women who used talc for the longest period of time had the highest risk of developing ovarian cancer.

Twenty Percent of American Households Use J & J Brand of Talc

Baby powder is estimated to be an $18.8 million market in the U.S., with nearly 20 percent of U.S. households using the Johnson & Johnson brand. Since the late 1970’s, cornstarch has been widely substituted for talc as an absorbent, and while J & J offers baby powders with cornstarch, it also continues to offer products containing talc. The Fox case was a bellwether trial, and since the jury clearly found the evidence compelling, others who have filed lawsuits against Johnson & Johnson can be hopeful about their own case.

Contact Our New Jersey Consumer Class Action Lawyers

At Golomb Legalour attorneys have been involved in the talcum powder litigation in New Jersey State Court from the beginning over two years ago. From the very first case, we have been strong legal advocates for our injured clients and for consumers throughout New Jersey, Philadelphia, and across the United States. In fact, Golomb Legalis the trial counsel in the first New Jersey bellwether case set to begin trial in July 2016.

If you or someone you love has developed ovarian cancer after using talc powder, we can help. To learn more about your legal options or to schedule a free consultation call the dangerous drug lawyers at Golomb Legaltoday at 1-800-355-3300 or 1-215-985-9177 or fill out our confidential Contact Form.

The national dangerous drug lawyers at Golomb Legalhave successfully represented individuals in Philadelphia, Pennsylvania, New Jersey, and throughout the United States.